Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rommer

Showing results (201-210 of 220) with videos related to

Pageof 22
Sort By:
Neurology(R) Neuroimmunology & Neuroinflammation|June 10, 2021
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive PatientsIlya Ayzenberg, Daniel Richter, Eugenia Henke, et al.
Neurology|August 28, 2024
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI ActivityGabriel Bsteh, Marie L Aicher, Janette F Walde, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Wiener Klinische Wochenschrift|August 9, 2023
[S1 guidelines for the management of postviral conditions using the example of post-COVID-19]Susanne Rabady, Kathryn Hoffmann, Martin Aigner, et al.
Ebiomedicine|September 8, 2023
Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophyIsabelle Weinhofer, Paulus Rommer, Andreas Gleiss, et al.
Neurology and Therapy|July 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysisMahdi Barzegar, Sara Samadzadeh, Bertrand Audoin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2026
Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case SeriesPaulus S Rommer, Wei Jiang, Jan P Nolte, et al.
Neurology|December 5, 2019
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersMarius Ringelstein, Jens Harmel, Hanna Zimmermann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2023
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-StudyMartin W Hümmert, Franziska Bütow, Daria Tkachenko, et al.
JAMA Neurology|March 9, 2026
Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory DiseasesHannes Vietzen, Laura M Kühner, Sarah M Berger, et al.
Pageof 22

Showing results (201-210 of 220) with videos related to

Sort By:
Pageof 22
Neurology(R) Neuroimmunology & Neuroinflammation|June 10, 2021
Pain, Depression, and Quality of Life in Neuromyelitis Optica Spectrum Disorder: A Cross-Sectional Study of 166 AQP4 Antibody-Seropositive PatientsIlya Ayzenberg, Daniel Richter, Eugenia Henke, et al.
Neurology|August 28, 2024
Association of Disease-Modifying Treatment With Outcome in Patients With Relapsing Multiple Sclerosis and Isolated MRI ActivityGabriel Bsteh, Marie L Aicher, Janette F Walde, et al.
Journal of Neuroinflammation|September 5, 2020
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 1: Results from 163 lumbar punctures in 100 adult patientsSven Jarius, Hannah Pellkofer, Nadja Siebert, et al.
Wiener Klinische Wochenschrift|August 9, 2023
[S1 guidelines for the management of postviral conditions using the example of post-COVID-19]Susanne Rabady, Kathryn Hoffmann, Martin Aigner, et al.
Ebiomedicine|September 8, 2023
Biomarker-based risk prediction for the onset of neuroinflammation in X-linked adrenoleukodystrophyIsabelle Weinhofer, Paulus Rommer, Andreas Gleiss, et al.
Neurology and Therapy|July 15, 2026
Comparative Evaluation of Rituximab Versus Approved Therapies in Aquaporin-4-IgG-Positive Neuromyelitis Optica Spectrum Disorder: A Systematic Review and Network Meta-analysisMahdi Barzegar, Sara Samadzadeh, Bertrand Audoin, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|February 11, 2026
Complement Inhibition for Acute Neuromyelitis Optica Spectrum Disorder Attacks: Insights From an International Case SeriesPaulus S Rommer, Wei Jiang, Jan P Nolte, et al.
Neurology|December 5, 2019
Longitudinal optic neuritis-unrelated visual evoked potential changes in NMO spectrum disordersMarius Ringelstein, Jens Harmel, Hanna Zimmermann, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 24, 2023
Effects of the COVID-19 Pandemic on Patients With NMO Spectrum Disorders and MOG-Antibody-Associated Diseases: COPANMO(G)-StudyMartin W Hümmert, Franziska Bütow, Daria Tkachenko, et al.
JAMA Neurology|March 9, 2026
Epstein-Barr Virus Antibodies to Differentiate Multiple Sclerosis From Other Neuroinflammatory DiseasesHannes Vietzen, Laura M Kühner, Sarah M Berger, et al.
Pageof 22